References
- Tisdale AK, Chwalisz B. Neuro-ophthalmic manifestations of coronavirus disease 19. Curr Opin Ophthalmol. 2020;31(6):489–494. doi:https://doi.org/10.1097/ICU.0000000000000707.
- Zhou S, Jones-Lopez EC, Soneji DJ, Azevedo CJ, Patel VR. Myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and myelitis in COVID-19. J Neuroophthalmol. 2020;40(3):398–402. doi:https://doi.org/10.1097/WNO.0000000000001049.
- Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–783. doi:https://doi.org/10.1016/S1474-4422(20)30221-0.
- Román GC, Spencer PS, Reis J, et al. The neurology of COVID-19 revisited: a proposal from the environmental neurology specialty group of the world federation of neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. doi:https://doi.org/10.1016/j.jns.2020.116884.
- Costello F, Dalakas MC. Cranial neuropathies and COVID-19: neurotropism and autoimmunity. Neurology. 2020;95(5):195–196. doi:https://doi.org/10.1212/WNL.0000000000009921.
- Chen X, Laurent S, Onur OA, et al. A systematic review of neurological symptoms and complications of COVID-19. J Neurol. 2021;268(2):392–402. doi:https://doi.org/10.1007/s00415-020-10067-3.
- Berger JR. COVID-19 and the nervous system. J Neurovirol. 2020;26(2):143–148. doi:https://doi.org/10.1007/s13365-020-00840-5.
- Khairallah M, Kahloun R, Abroug N, et al. Infectious optic neuropathies: a clinical update. Eye Brain. 2015;7:59–81. doi:https://doi.org/10.2147/EB.S69173.
- Chen JJ, Flanagan EP, Jitprapaikulsan J, et al. Myelin oligodendrocyte glycoprotein antibody–positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195:8–15. doi:https://doi.org/10.1016/j.ajo.2018.07.020.
- Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, et al. False-negative results of initial RT-PCR assays for COVID-19: a systematic review. PLoS One. Dec 10 2020;15(12):e0242958. doi:https://doi.org/10.1371/journal.pone.0242958.
- de Ruijter NS, Kramer G, Gons RAR, Hengstman GJD. Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: a case report. Mult Scler Relat Disord. 2020;46:102474. doi:https://doi.org/10.1016/j.msard.2020.102474.
- Chen JJ, Bhatti MT. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol. 2020;33(1):47–54. doi:https://doi.org/10.1097/WCO.0000000000000766.
- Nakamura M, Iwasaki Y, Takahashi T, et al. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. Mult Scler Relat Disord. 2017;17:148–150. doi:https://doi.org/10.1016/j.msard.2017.07.023.
- Khan A, Panwala H, Ramadoss D, Khubchandani R. Myelin oligodendrocyte glycoprotein (MOG) antibody disease in a 11-year-old with COVID–19 infection. Indian J Pediatr. 2021;20:1–2.